Atlas Venture

Spruce Bio Raises $88M for Clinical Tests of Rare Endocrine Disease Drug

Spruce Bio Raises $88M for Clinical Tests of Rare Endocrine Disease Drug

3 days ago   |   Xconomy

Spruce Biosciences has raised $88 million to advance clinical testing of a drug for a rare inherited endocrine disorder that can lead to a potentially life-threatening hormonal...
Read more ...

Thymus atlas could spark new treatments for cancer, autoimmune disease

3 days ago   |   Fierce Biotech

Scientists have mapped the thymus, a gland in the chest that makes disease-fighting white blood cells, across the human life span. This “cell atlas” could help researchers...
Read more ...

EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis' Device

EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis' Device

4 days ago   |   Xconomy

Many companies are working to develop new drugs that target harmful proteins associated with neurodegenerative diseases. EnClear Therapies has raised a $10 million Series A...
Read more ...

DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer

4 days ago   |   Springer   |   2 articles

Abstract Background Accumulating evidence indicates that long non-coding RNAs participate in progression of gastric cancer. Nevertheless, the function and expression level of...
Read more ...

Imara Reveals IPO Plan as Sickle Cell Drug Advances in the Clinic

Imara Reveals IPO Plan as Sickle Cell Drug Advances in the Clinic

5 days ago   |   Xconomy   |   2 articles

Sickle cell disease research is seeing a flurry of activity with several companies currently testing therapies for the genetic blood disorder and one company recently receiving...
Read more ...

Research Associate - Sequencing Applications - Singular Genomics - San Diego, CA

9 days ago   |   San Diego Biotechnology   |   6 articles

Singular Genomics is a venture capital backed biotech company in La Jolla, California. Document experimental approach and results.From Indeed - Fri, 14 Feb 2020 17:39:29 GMT...
Read more ...

Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer

Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer

11 days ago   |   Xconomy

The RAS family of proteins are one of the hottest targets in cancer research despite being one of the hardest for drug hunters to hit. Revolution Medicines has raised $238...
Read more ...

Scientist I, Bioinformatics - Singular Genomics - San Diego, CA

12 days ago   |   San Diego Biotechnology   |   3 articles

Identify biases within sequencing data to improve experimental design and process development. Singular Genomics is a venture capital backed biotech company in...From Indeed...
Read more ...

Sr. Intellectual Property Specialist - Singular Genomics - San Diego, CA

13 days ago   |   San Diego Biotechnology   |   7 articles

Singular Genomics is a venture capital backed biotech company in La Jolla, California. We are located in the center of the Biotech hub on the Torrey Mesa close...From Indeed...
Read more ...

Enterprise Therapeutics nabs Novartis VC exec as new CMO

14 days ago   |   Fierce Biotech

Britain-based biotech Enterprise Therapeutics has hired Novartis Venture Fund managing director David Morris, M.D., as its next chief medical officer.
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Invetx Fetches $15M to Develop Biologic Drugs for Man's Best Friend

Veterinarians have a saying that a cat is not a small dog, says Invetx CEO Juergen Horn. Obviously, a dog of any size isn't the same as a human. But Horn, a veterinarian, says... Read more ...

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

Lundbeck's Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

A migraine drug that Lundbeck added to its pipeline via its nearly $2 billion acquisition of Alder BioPharmaceuticals won FDA approval on Friday. The drug, eptinezumab , is... Read more ...

Arima Genomics Completes Series A Financing

SAN DIEGO--Arima Genomics, Inc., a company focused on research tools to accelerate the understanding of genome sequence and structure toward their role in human health and... Read more ...

Viking Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO, Feb. 24, 2020 /PRNewswire/ - Viking Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and... Read more ...

Molecular characterization and overexpression analyses of secologanin...

Abstract Camptothecin is a high-value anti-cancerous compound produced in many taxonomically unrelated species. Its biosynthesis involves a complex network of pathways and a... Read more ...

Modulation of the Purine Pathway for Riboflavin Production in Flavinogenic...

Riboflavin is an indispensable nutrient for humans and animals, since it is the precursor of the essential coenzymes FMN and FAD, involved in variety of metabolic reactions... Read more ...

A Critical Review of Genome Editing and Synthetic Biology Applications in...

Being the green gold of the future, microalgae and cyanobacteria have recently attracted considerable interest worldwide, for they can be used to produce different kinds of... Read more ...

Biodegradation of penicillin G from industrial bacteria residue by...

An efficient biodegradation-strengthening approach was developed to improve penicillin G degradation from industrial bacterial residue in an expanded bed adsorption bioreactor... Read more ...

More clues for how the monkeyflower got its spots

The monkeyflower, or Mimulus, though possessing a relatively simple genome is able to produce a stunning array of pigmentation patterns. A team of researchers is one step... Read more ...

A deep dive into cellular aging

Scientists have discovered that mitochondria trigger senescence, the sleep-like state of aged cells, through communication with the cell's nucleus -a nd identified an... Read more ...